Labcorp shares jump 10% after earnings beat and raised full-year outlook

what happened

Shares of Labcorp Holdings rose roughly 10.3% in the afternoon session after the company reported third-quarter 2026 results that beat Wall Street forecasts and raised its full-year outlook. The details come from StockStory, which cites the company's press release.

Labcorp posted third-quarter revenue of $3.81 billion, up from $3.56 billion a year earlier and above analysts' estimate of $3.76 billion. Adjusted earnings per share rose to $4.78 from $4.18, topping the consensus of $4.65. Diluted earnings per share climbed to $3.22 from $3.12.

For 2026, the company now expects enterprise revenue growth of 5.9% to 6.7%, and adjusted earnings per share of $18.30 to $18.70. According to the report, at $365.79 a share the stock set a new 52-week high.

why it matters

For markets, the raised forecast matters as much as the quarter itself, since it suggests management sees steady demand for its services. Surprises like this tend to reset how investors value the stock and affect sentiment across medical diagnostics. A move of about 10% in a stock that rarely swings more than 5% signals that the news carried weight.

market impact

Labcorp stock: strong quarter and higher guidance support the shares

• ▲Labcorp shares (LH) pressure up — revenue and earnings beat expectations and the 2026 outlook was raised

tags

instruments